Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Collen

Showing results (491-500 of 715) with videos related to

Pageof 72
Sort By:
Circulation|October 1, 1990
Validity of enzyme-linked immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysisP R Eisenberg, A S Jaffe, D C Stump, et al.
Journal of the American College of Cardiology|September 1, 1992
Correlation between level of heparinization and patency of the infarct-related coronary artery after treatment of acute myocardial infarction with alteplase (rt-PA)J Arnout, M Simoons, D de Bono, et al.
The Journal of Clinical Investigation|November 20, 1998
Reduced transplant arteriosclerosis in plasminogen-deficient miceL Moons, C Shi, V Ploplis, et al.
Circulation|October 15, 1995
Thrombolytic therapy of peripheral arterial occlusion with recombinant staphylokinaseS Vanderschueren, L Stockx, G Wilms, et al.
Journal of Cardiovascular Pharmacology|August 1, 1990
Pharmacokinetics and coronary thrombolytic properties of two human tissue-type plasminogen activator variants lacking the finger-like, growth factor-like, and first kringle domains (amino acids 6-173) in a canine modelZ Wu, F Van de Werf, T Stassen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 22, 1998
Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genesH R Lijnen, B Van Hoef, F Lupu, et al.
The Journal of Clinical Investigation|July 17, 1998
Substitution of the carboxyl-terminal domain of apo AI with apo AII sequences restores the potential of HDL to reduce the progression of atherosclerosis in apo E knockout miceP Holvoet, S Danloy, E Deridder, et al.
Thrombosis and Haemostasis|October 6, 1997
Characterization and targeting of the murine alpha2-antiplasmin geneK Okada, H R Lijnen, M Dewerchin, et al.
Circulation|December 31, 1997
Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in miceP Carmeliet, L Moons, R Lijnen, et al.
Thrombosis Research|December 15, 1990
Correlations between t-PA and PAI-1 antigen and activity and t-PA/PAI-1 complexes in plasma of control subjects and of patients with increased t-PA or PAI-1 levelsM C Alessi, I Juhan-Vague, P J Declerck, et al.
Pageof 72

Showing results (491-500 of 715) with videos related to

Sort By:
Pageof 72
Circulation|October 1, 1990
Validity of enzyme-linked immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysisP R Eisenberg, A S Jaffe, D C Stump, et al.
Journal of the American College of Cardiology|September 1, 1992
Correlation between level of heparinization and patency of the infarct-related coronary artery after treatment of acute myocardial infarction with alteplase (rt-PA)J Arnout, M Simoons, D de Bono, et al.
The Journal of Clinical Investigation|November 20, 1998
Reduced transplant arteriosclerosis in plasminogen-deficient miceL Moons, C Shi, V Ploplis, et al.
Circulation|October 15, 1995
Thrombolytic therapy of peripheral arterial occlusion with recombinant staphylokinaseS Vanderschueren, L Stockx, G Wilms, et al.
Journal of Cardiovascular Pharmacology|August 1, 1990
Pharmacokinetics and coronary thrombolytic properties of two human tissue-type plasminogen activator variants lacking the finger-like, growth factor-like, and first kringle domains (amino acids 6-173) in a canine modelZ Wu, F Van de Werf, T Stassen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 22, 1998
Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genesH R Lijnen, B Van Hoef, F Lupu, et al.
The Journal of Clinical Investigation|July 17, 1998
Substitution of the carboxyl-terminal domain of apo AI with apo AII sequences restores the potential of HDL to reduce the progression of atherosclerosis in apo E knockout miceP Holvoet, S Danloy, E Deridder, et al.
Thrombosis and Haemostasis|October 6, 1997
Characterization and targeting of the murine alpha2-antiplasmin geneK Okada, H R Lijnen, M Dewerchin, et al.
Circulation|December 31, 1997
Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in miceP Carmeliet, L Moons, R Lijnen, et al.
Thrombosis Research|December 15, 1990
Correlations between t-PA and PAI-1 antigen and activity and t-PA/PAI-1 complexes in plasma of control subjects and of patients with increased t-PA or PAI-1 levelsM C Alessi, I Juhan-Vague, P J Declerck, et al.
Pageof 72